文献速递免疫规划卫生政策与健康促进

自闭症成人自我报告的新冠疫苗接种接受度与犹豫度

Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults.
PubMed 文献 · Vaccine · 2022-04-22

本研究描述自闭症成人的新冠疫苗接种状态与自我报告偏好,并识别与接种接受度相关的因素。接种接受者更可能报告疫情期间孤独感增加、居住在人口更多的县以及在2020年美国大选中拜登获胜的县。保护他人的意愿、对感染新冠的担忧与信任疫苗安全性呈正相关;疫苗犹豫者中常见对疫苗安全性的担忧。

要点

  • 接种接受者更可能报告疫情期间孤独感增加、居住在人口更多的县(p=0.02)及拜登获胜县(p<0.001)。
  • 保护他人的意愿、对感染新冠的担忧与信任疫苗安全性呈正相关(p<0.001)。
  • 疫苗犹豫者中常见对疫苗安全性的担忧,而整体不担心新冠则不常见。

核心结论

  • 识别与自闭症成人新冠疫苗接种接受度相关的因素可提高接种率并支持公共卫生。
  • 基于脆弱群体自我报告的新冠亲身经历制定健康促进策略对公共卫生影响至关重要。

研究设计与样本

  • 本研究描述自闭症成人的新冠疫苗接种状态与自我报告偏好,并识别相关因素。

主要发现

  • 接种接受者更可能报告疫情期间孤独感增加、居住在人口更多的县(p=0.02)及拜登获胜县(p<0.001)。
  • 保护他人的意愿、对感染新冠的担忧与信任疫苗安全性呈正相关(p<0.001)。
  • 疫苗犹豫者中常见对疫苗安全性的担忧,而整体不担心新冠则不常见。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Identifying factors associated with COVID-19 vaccination acceptance among vulnerable groups, including autistic individuals, can increase vaccination rates and support public health. The purpose of this study was to determine differences among autistic adults who reported COVID-19 vaccination acceptance from those who did not. In this study we describe COVID-19 vaccination status and self-reported preferences among autistic adults and identify related factors. Vaccine accepters were more likely to report increased loneliness during COVID-19, lived in more populous counties (p = 0.02), and lived in counties won by President Biden in the 2020 US presidential election (p < 0.001). Positive correlations were found between desire to protect others, concern about contracting COVID-19, and trusting vaccine safety (p < 0.001). Concern about vaccine safety was common among the vaccine hesitant, while lack of concern about COVID-19 overall was not. Identifying health promotion strategies based on self-reported, lived experiences about COVID-19 among vulnerable groups is key for public health impact.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Shea LL, Becker A, Lee BK, et al. Self-reported COVID-19 vaccination acceptance and hesitancy among autistic adults. Vaccine. 2022. PMID: 35484038. doi:10.1016/j.vaccine.2022.04.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。